Cannabis oil: a final hope
Many people have turned to medicinal cannabis from the black
market to treat conditions that other legal alternatives have not been
able to treat. This raises concerns, such as quality control, testing,
and research within the field.
Jenny Hallam, a medicinal cannabis campaigner and producer,
speaks about her role in which she previously had supplied oil to
those who had exhausted all other options, why it’s so important,
and how she first started in the medicinal cannabis field.
http://de9znd9hicg5y.cloudfront.net/wp-content/uploads/2017/06/01075349/Jenny-Hallam-1-6-17.mp3
**********************************
An Australian tea tree farm just received $1.49 million to develop 'medical
cannabis honey' By Peter Farquhar 1/5/17
An organic tea tree farm in New South Wales
has received a $1.49 million investment to
help develop medical cannabis honey.
Jenbrook supplies raw tea tree oil and honey
products to the US through Naturally Aust
Product. Next month, it’s expected to hit
$1.6m annualised monthly revenue, a 100%
increase from June 2016.
The company has also been exploring a
medical hemp honey, produced by bees
pollinating on the nectar of medicinal
cannabis plants. It’s working with Southern
Cross University on research into its health
benefits. EVE Investments has kicked in the
$1.49 million to help get the product to
market.
In return, EVE – an ASX-listed technology
investment company – will acquire a 50%
interest in Jenbrook.
Jenbrook is based in Alstonville in the NSW
Northern Rivers region. Subject to the
transaction, its assets also include Jendale and
Robyndale tea tree plantations in the heart of
the Bungawalbyn Valley Basin, and the
patented extraction technique used to produce
high potency tea tree oil.
The plantations are also a source of melaleuca
honey, and Jenbrook is currently validating a
production process which is expected to yield
honey with “superior antibacterial properties”
to manuka honey.
It claims the “meluka” honey has potential as
a treatment for “certain human diseases”.
“The business is at a very exciting point and
is uniquely positioned to disrupt the
approximate $2.1 billion global manuka
honey market,” EVE’s investments director
Ben Rohr said.
The acquisition will be facilitated through the
creation of a new company (NewCo) that will
be a 50/50 joint venture between EVE
Investments and Jenbrook.
https://www.businessinsider.com.au/an-australian-
tea-tree-farm-just-received-1-49-million-to-develop-
medical-cannabis-honey-2017-5